Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001104659-21-099733

Chief Scientific Officer bought 1,353 shares at $15.00 ($20,295)

  • Chief Scientific Officer acquired 5,040 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Hall Brett Matthew · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-03 Conversion : show line 1 in the form +5,040 5,040 D
2021-08-03 Purchase : show line 2 in the form +1,353 $15.00 $20,295 6,393 D
Open-market purchases · 1,353 sh · avg $15.00 · $20,295

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2021-08-03 Conversion : show line 3 in the form Series A Preferred Stock −1,636 1,636 0 D
2021-08-03 Conversion : show line 4 in the form Series B Preferred Stock −3,404 3,404 0 D
Loading xslF345X03/tm2123807-6_4seq1.xml…